Rocket Pharmaceuticals, Inc.
RCKT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001281895
In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 194 | 1 | 185 | −8 |
| Shares | 89.0M | 1.07M | 92.4M | +4.42M (+5.0%) |
| Value | $2.67B | $32.1M | $2.48B | −$151.1M (−5.7%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| First Turn Management, LLC | 250,870 | $6.76M | 1.01% |
| Qube Research & Technologies Ltd | 177,524 | $4.78M | 0.01% |
| Nicholas Investment Partners, LP | 119,137 | $3.21M | 0.33% |
| Neuberger Berman Group LLC | 114,617 | $3.09M | 0.00% |
| Twinbeech Capital LP | 14,122 | $380.4K | 0.01% |
| Aquatic Capital Management LLC | 13,100 | $352.9K | 0.01% |
| Cetera Investment Advisers | 12,746 | $343.4K | 0.00% |
| Legato Capital Management LLC | 11,159 | $300.6K | 0.04% |
| XTX Topco Ltd | 9,507 | $256.1K | 0.03% |
| HSBC Holdings PLC | 8,048 | $216.7K | 0.00% |
| Pearl River Capital, LLC | 7,712 | $207.8K | 0.03% |
| Quest Partners LLC | 6,180 | $166.5K | 0.03% |
| KBC Group NV | 2,109 | $57.0K | 0.00% |
| STRS Ohio | 1,700 | $45.0K | 0.00% |
| Pacer Advisors, Inc. | 1,528 | $41.2K | 0.00% |
| Fernwood Investment Management, LLC | 1,057 | $28.5K | 0.01% |
| Evermay Wealth Management LLC | 25 | $674 | 0.00% |
| Massmutual Trust Co FSB | 25 | $674 | 0.00% |
| Rothschild Investment LLC | 5 | $135 | 0.00% |
Sold out (27)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
Not filed for Q1 2024 yet (1)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Putnam Investments LLC | 1,069,715 | $32.1M |